Try 50 free Series 161 practice questions across the official topic areas, with answers and explanations, then continue with the full Securities Prep question bank.
This free full-length Series 161 practice exam includes 50 original Securities Prep questions across the official topic areas.
The questions are original Securities Prep practice questions aligned to the exam outline. They are not official exam questions and are not copied from any exam sponsor.
Count note: this page uses the full-length practice count maintained in the Mastery exam catalog. Some exam sponsors publish total questions, scored questions, duration, or unscored/pretest-item rules differently; always confirm exam-day rules with the sponsor.
For a compact topic review before or after this set, use the Series 161 Cheat Sheet on SecuritiesMastery.com.
| Item | Detail |
|---|---|
| Issuer | FINRA |
| Exam | Series 161 |
| Official route name | Series 161 — Supervisory Analyst Qualification Examination (Part I: Regulations) |
| Full-length set on this page | 50 questions |
| Exam time | 90 minutes |
| Passing score | 72 |
| Topic areas represented | 2 |
| Topic | Approximate official weight | Questions used |
|---|---|---|
| Research Communications Review | 68% | 34 |
| Research Liaison Duties | 32% | 16 |
Topic: Research Liaison Duties
A supervisory analyst is reviewing a pending rating-change report. The issuer is not on the firm’s restricted list, the analyst’s Reg AC certification is on file, and the report’s disclosures are complete. Firm policy permits research personnel and related accounts to trade covered issuers only if the trade is precleared and later matched to duplicate confirms or account statements. Compliance learns that the analyst’s spouse sold the issuer’s shares through an outside account three days earlier, but no preclearance approval or duplicate-account records were retained. What is the primary compliance risk?
Best answer: D
Explanation: Without retained preclearance records and duplicate confirms or statements for the related account, the firm cannot demonstrate compliance with research-personnel personal-trading restrictions.
The key red flag is missing evidence that the related-account trade complied with the firm’s personal-trading controls. When a firm requires preclearance and post-trade monitoring for research personnel and related accounts, it must retain records showing those steps occurred.
This item turns on supervisory evidence of compliance with personal-account trading restrictions for research personnel. The stem says the firm allows trades only if they are precleared and then matched to duplicate confirms or account statements. Because the spouse’s outside-account trade occurred and the firm retained neither the preclearance approval nor the follow-up account records, the firm cannot prove that the trade was reviewed, permitted, and monitored under its policy.
Those records matter because research-personnel restrictions typically extend to related accounts, not just the analyst’s own account. An annual attestation or general policy is not enough when a specific trade must be reconstructed and tested against firm restrictions. The main problem is therefore books-and-records evidence of personal-trading compliance, not report content or release mechanics. The key takeaway is that missing control records are the decisive supervisory red flag.
Topic: Research Communications Review
A firm is revising its written supervisory procedures to address selective dissemination of research. Which provision most directly operationalizes that standard?
Best answer: D
Explanation: Selective dissemination is controlled by release procedures that prevent favored recipients from receiving research before the broader intended audience.
Selective dissemination is primarily a dissemination-control issue. Written supervisory procedures should require secure handling before publication and firm-controlled distribution so intended recipients receive the research at substantially the same time.
The core concept is that research must not be given early to favored customers, sales personnel, issuers, or other outsiders. To operationalize that standard, written supervisory procedures should focus on how approved research is held and released: limit pre-release access to legitimate need-to-know personnel, use controlled distribution channels, and release the report to the intended audience on a substantially simultaneous basis.
Controls such as issuer fact-checking, watch-list administration, or public-appearance oversight may matter for other reasons, but they do not directly solve selective dissemination.
Topic: Research Communications Review
Before approving a research report on Delta Medical, a supervisory analyst reviews the analyst compensation record below.
Exhibit: Analyst compensation note
Annual bonus factors:
- forecast accuracy
- research quality
- client feedback
- firmwide pretax margin
Firmwide pretax margin includes investment banking, trading,
and asset-management results.
No bonus metric is tied to any specific underwriting,
advisory mandate, or issuer.
Analyst certification on file:
"My views are my own and no part of my pay is tied to any
specific recommendation, transaction, or issuer."
Which action is best supported by the exhibit?
Best answer: A
Explanation: The exhibit shows only an indirect link through firmwide results, supporting disclosure review rather than automatic recusal or a per se prohibition.
The exhibit shows an indirect connection between compensation and investment banking through firmwide pretax margin, while also stating that no pay metric is tied to a specific transaction or issuer. That supports a disclosure-related review before approval, not automatic recusal or a finding that the compensation arrangement is prohibited on its face.
Research conflict rules distinguish between compensation tied to a specific investment banking transaction and compensation influenced more generally by overall firm results. Here, the note says firmwide pretax margin is one bonus factor and that this margin includes investment banking results, so the supervisory analyst should recognize a compensation-related disclosure issue. But the same exhibit also says no bonus metric is tied to any specific underwriting, advisory mandate, transaction, or issuer, which undercuts a recusal or prohibition conclusion based on these facts alone.
The best supervisory response is to confirm the proper compensation disclosure is included before approval and dissemination. A decision to remove the analyst or block publication would require stronger facts showing a specific-deal or issuer-linked compensation tie.
Topic: Research Liaison Duties
A supervisory analyst is reviewing whether to approve a draft rating change on Harbor Bio. Based on the exhibit, which action is most appropriate before any dissemination?
Exhibit: Internal email excerpt
From: Senior Analyst
To: Supervisory Analyst
Subject: Harbor Bio draft upgrade
- IR call today included: company is "finalizing a marketed follow-on for next week."
- The offering has not been publicly announced.
- Sales asked whether research can be released before the desk gets any distribution role.
- Draft report changes rating from Hold to Buy and raises the price target.
Best answer: D
Explanation: The exhibit indicates possible MNPI and distribution sensitivity, so approval and dissemination should stop until legal/compliance reviews it.
The email shows two red flags at once: possible material nonpublic information about an unannounced follow-on and potential distribution sensitivity because sales is asking about release timing. A supervisory analyst should not approve or circulate the report until legal/compliance has reviewed the situation and any needed restrictions are in place.
When research may intersect with unannounced offering information or possible distribution activity, the supervisory analyst’s role is to stop normal approval flow and escalate. Here, the analyst reports that issuer relations discussed a marketed follow-on planned for next week and that the offering is not yet public. That creates a strong MNPI concern. The separate note that sales wants the report released before the desk gets any distribution role adds a distribution-sensitivity concern.
Before approval or dissemination, legal/compliance should determine whether the issuer or security belongs on a watch list or restricted list, whether publication must be delayed, and whether any internal barriers or dissemination controls are required. Analyst certification is not a substitute for that review, and limiting circulation to sales would still be an improper internal dissemination step.
The key takeaway is that suspected MNPI or offering sensitivity requires escalation first, not conditional approval.
Topic: Research Liaison Duties
A supervisory analyst reviews two planned analyst appearances about covered issuers.
Which appearance is most appropriate for the supervisory analyst to clear as having complete public-appearance disclosures?
Best answer: C
Explanation: It directly discloses the known conflict during the appearance, while the TV interview omits a known specific conflict and relies on a generic website reference.
Public-appearance disclosures can be oral or written, but they must specifically communicate known conflicts at the time of the appearance. The webinar does that; the TV interview does not, because a generic website reference does not substitute for disclosing a known advisory-board conflict.
The key issue is whether the audience receives a specific, timely disclosure of known conflicts during the public appearance. For analyst appearances in media or similar settings, required conflict disclosures may be made orally or in writing, but they must be complete enough to tell the audience what the actual conflict is.
Here, the webinar satisfies that standard because the analyst’s ownership interest is disclosed directly on the opening slide and repeated orally. By contrast, the TV interview omits a known household/advisory-board conflict and substitutes only a general pointer to the firm’s website. That does not adequately communicate the specific conflict to the audience during the appearance.
The closest trap is treating website availability as enough by itself; it is not when a known conflict is left undisclosed in the appearance itself.
Topic: Research Communications Review
A supervisory analyst reviews a two-page written “Regional Banks Update” that will be emailed to retail clients and posted on the firm’s website. The piece discusses five named bank stocks, reiterates the analyst’s buy/hold/sell ratings, raises one price target, and states that another issuer is expected to underperform peers. It is not part of a live event or interview. Which action best aligns with research-supervision standards?
Best answer: A
Explanation: Because it is a written communication with issuer-specific analysis and investment opinions, it falls within the research report definition and should undergo research-report review before release.
This communication is a research report because it is written, broadly disseminated, and contains issuer-specific analysis, ratings, and a price-target change. Those features make it more than general market commentary or sales material, so research-report approval and required disclosures should be completed before release.
The core issue is whether the communication contains the type of written analysis and investment opinion that makes it a research report. Here, the piece names specific issuers, repeats ratings, changes a price target, and expresses an expectation that one issuer will underperform. That is issuer-specific research content, not merely broad economic or market commentary.
A supervisory analyst should therefore treat the item as a research report and confirm the proper approval path, required disclosures, and dissemination controls before publication. The fact that the document is only two pages long does not change its classification. What matters is the substance of the communication and whether it provides analysis or recommendations about securities or issuers. A sector title does not remove research-report status when the content includes specific covered companies and investment views.
Topic: Research Communications Review
A supervisory analyst is reviewing a same-day research note on a retail issuer. The package shows all standard firm disclosures, analyst certification, restricted-list clearance, and a time-stamped dissemination plan.
Exhibit: Approval package note
Draft language: "Weekend calls with several store managers indicate demand
has fallen off a cliff, and the company is likely to miss the quarter."
Workpapers attached: one email from the analyst:
"Negative market color from contacts."
No source log, question list, corroboration summary, or cautionary description of the anecdotal limits is included. Which missing item is the most important supervisory gap before the note can be approved?
Best answer: A
Explanation: Without documented source basis and qualified framing, the note reads like unsupported rumor rather than properly limited observational research.
The key deficiency is the lack of documentation and caution around the channel checks. Anecdotal market color can be used only if the supervisory analyst can verify its basis and ensure the draft does not present unverified observations as firm fact or prediction.
Channel checks are not automatically improper, but they must be handled with care. Here, the draft uses strong, predictive language while the file contains only vague “negative market color” and no supporting record of who was contacted, what was asked, how limited the sample was, whether anything was corroborated, or how the observations should be described. That creates a rumor-treatment problem.
Before approval, the supervisory analyst should require a documented basis memo and revised language that attributes the observations, states their limitations, and avoids turning anecdotal comments into definitive factual claims or earnings predictions. Other disclosure or process enhancements may be helpful, but they do not fix the central defect: the research package does not support the statement well enough to distinguish it from rumor.
Topic: Research Communications Review
A supervisory analyst reviews a research report that reiterates a buy rating and raises the price target for a medical-device issuer. The thesis depends on rapid adoption of a newly launched product. The report’s body text emphasizes upside catalysts, while discussion of possible regulatory limits, single-supplier dependence, and execution risk appears only in a standard disclosure section at the end. In deciding whether the report is ready for approval, each of the following conclusions is appropriate EXCEPT:
Best answer: D
Explanation: Material risks and key limitations cannot be buried in generic boilerplate when they are central to the recommendation and price target.
Research must be fair and balanced, especially when a recommendation and price target depend on specific assumptions. If major uncertainties and downside factors are central to the thesis, they need meaningful prominence in the report itself; generic end-of-report boilerplate is not enough.
The core issue is fair balance in research communications. When a report highlights favorable catalysts in the main discussion but places key risks, uncertainties, or analytical limitations only in a generic disclosure section, the presentation is not appropriately balanced. A supervisory analyst should look for whether investors can readily see what could impair the thesis, not just whether some risk language exists somewhere in the document.
If the rating or price target depends on launch success, the report should clearly present material downside factors such as regulatory constraints, supplier concentration, execution risk, and any important limitations in the analysis with meaningful prominence. Boilerplate can supplement a tailored risk discussion, but it should not replace it. The closest distractors all improve balance; the flawed approach is treating generic disclosure as sufficient by itself.
Topic: Research Communications Review
A firm has joined the underwriting syndicate for an issuer’s follow-on offering, and legal has notified research that the firm is a distribution participant for Regulation M purposes. No exception has been cleared. The supervisory analyst is asked to review two same-day items: a single-issuer note reaffirming the issuer’s rating and raising its price target, and a broad-based utilities market commentary that does not mention the issuer. Which supervisory response best matches these facts?
Best answer: C
Explanation: Issuer-specific research should be held and escalated when no Regulation M exception is available, while unrelated broad commentary may follow the normal approval path.
Regulation M publication limits turn on the firm’s status as a distribution participant and whether an exception applies. Here, the issuer-specific note should not be published without cleared relief, but unrelated broad market commentary is not barred on these facts and can proceed through ordinary supervisory review.
The key issue is that publication planning ignored a Regulation M restriction tied to an active distribution. Once the firm is acting as a distribution participant and no exception has been cleared, the supervisory analyst should stop issuer-specific research publication rather than try to solve the problem with extra disclosures. The single-issuer note directly concerns the offering issuer and includes a rating and price-target update, so it requires a hold and escalation to legal/compliance. By contrast, the broad-based utilities commentary does not mention the issuer, so the Regulation M concern described in the stem does not attach to it in the same way; it can move through the normal approval process if otherwise fair, balanced, and properly supervised.
The takeaway is that disclosure language does not cure a timing restriction, and unrelated market commentary is not automatically frozen just because the firm is in a distribution.
Topic: Research Liaison Duties
Which statement is most accurate about reusing a research analyst’s slide deck that was preapproved for an earlier public appearance?
Best answer: D
Explanation: Previously approved materials may be reused only on a controlled basis when the content is still accurate, unchanged, and handled under firm supervisory procedures.
Previously approved public-appearance materials are not automatically good forever, but they also do not always require a brand-new review. Reuse is generally permissible only if the material is unchanged, still accurate, and the firm’s supervisory procedures allow reliance on the prior approval while required disclosures and records for the later event are still handled.
The key issue is supervisory control over reused public-appearance materials. A firm may allow a research analyst to reuse slides or a script from an earlier event without a full new review if the material has not been materially changed, remains current and fair, and the firm’s procedures permit reliance on the prior approval. If the content has been updated, has become stale, or no longer fits the later event, renewed supervisory review is needed before use. Even when reuse is permitted, the later appearance still must satisfy applicable disclosure and recordkeeping requirements. The wrong approaches are treating prior approval as permanent, making issuer consent the deciding test, or assuming every later use automatically requires a fresh review.
Topic: Research Communications Review
A supervisory analyst is reviewing a research report on a covered issuer for retail and institutional distribution. In addition to the analyst’s rating and price target, the report includes a new section recommending the issuer’s reverse convertible notes and explains barrier levels, knock-in events, and payoff outcomes under several stock-price scenarios. Standard issuer and analyst disclosures are included, the issuer is not on a restricted list, and supervisory analyst approval is otherwise complete, but no appropriately qualified structured-products or derivatives specialist has reviewed that section. What is the best supervisory action?
Best answer: B
Explanation: Complex structured-product and derivatives content requires the additional specialist review before the report can be approved for dissemination.
The decisive issue is the missing specialist review. Because the report adds complex structured-product content with derivative-like payoff features, supervisory analyst approval alone is not enough before dissemination.
When a research communication goes beyond ordinary equity analysis and includes complex structured-product or derivatives content, the supervisory analyst must confirm that the communication receives any required specialist review under the firm’s approval architecture before release. Here, the reverse convertible discussion introduces barrier, knock-in, and scenario-based payoff mechanics that create a separate product-complexity review issue. Standard disclosures, completed supervisory analyst review, and the absence of a restricted-list problem do not cure that missing control.
The best action is to stop dissemination until the appropriately qualified specialist reviews the section. Relabeling the material as educational or limiting initial distribution to institutions does not remove the need for the added review when the communication substantively recommends or analyzes a complex product.
Topic: Research Communications Review
A broker-dealer plans to email retail customers a favorable single-issuer report prepared by an unaffiliated research boutique. The firm will place its logo on the cover and send it through the firm’s normal research distribution system, but no supervisory analyst has reviewed it and the firm’s disclosure legend has not been added. Which action best aligns with research-supervision standards before dissemination?
Best answer: B
Explanation: Firm-branded redistribution adopts the report as a customer research communication, so internal supervisory review and required firm disclosures should precede dissemination.
When a firm republishes third-party research under its own branding and distribution system, it should not rely solely on the outside publisher’s approval. The firm should treat the piece as subject to its own research-supervision process, including supervisory review and firm-specific disclosures, before customers receive it.
The key issue is adoption and customer dissemination. By placing its logo on the report and sending it through the firm’s research channel, the firm is not acting as a passive messenger; it is using the material as a firm research communication. That means the firm should evidence its own supervisory review before release and confirm that required firm disclosures are included and the communication is fair and balanced. The outside research boutique’s authorship does not replace the firm’s internal control obligations once the firm republishes the material for its customers.
Changing the audience or routing method does not remove that obligation if the firm is still disseminating the report as its own customer-facing communication.
Topic: Research Communications Review
A firm plans to redistribute a research report after making material revisions to the analyst’s recommendation and price target. The original version already contained the analyst’s Regulation AC certification. Before the supervisory analyst approves redistribution, what should be verified?
Best answer: B
Explanation: A materially revised redistributed research report should be supported by a current analyst certification tied to the revised views being published.
Regulation AC is tied to the analyst’s expressed views in the research communication being distributed. When a report is materially revised and then redistributed, the supervisory analyst should confirm that the analyst has refreshed or reconfirmed the certification so it matches the revised content.
The core concept is that Regulation AC certification must match the analyst’s currently distributed views. If a research report is materially revised before redistribution, the original certification for the earlier version should not be treated as automatically sufficient for the new version. The supervisory analyst should verify that the analyst has refreshed or otherwise reconfirmed the certification so it applies to the materially revised recommendation, price target, or other substantive views.
This is a research-report certification issue, not a substitute-disclosure issue. A compliance or supervisory sign-off does not replace the analyst’s personal certification, and the separate quarterly certification framework for public appearances does not satisfy the requirement for a materially revised written research report. The key takeaway is to tie the certification to the exact communication being redistributed.
Topic: Research Communications Review
A firm is in a transaction-related quiet period for an issuer’s follow-on offering. A supervisory analyst is asked to approve a short client note stating only that the issuer filed a Form 8-K announcing a CFO resignation; the note would contain no rating, no price target, no earnings estimate, and no analyst view. Which statement is most accurate?
Best answer: B
Explanation: A quiet period restricts research publication, so the note may proceed only if supervisory review confirms it remains a factual communication outside research-report scope.
The key issue is whether the communication is a research report or a purely factual update. During a transaction-related quiet period, a note may be disseminated only if supervisory review confirms it stays factual and does not include opinions, recommendations, or other research content.
Quiet-period publication restrictions are aimed at research dissemination tied to the transaction, not every issuer-related fact. In this scenario, the proposed note describes an objective filing event and expressly excludes a rating, price target, earnings estimate, and analyst view. That means it may be permissible only if the firm’s review concludes the item is truly factual and should not be treated as a research report.
A supervisory analyst should verify that the note:
The closest trap is the idea that unchanged recommendations are harmless, but including a rating or price target would turn the communication back into research content.
Topic: Research Communications Review
A supervisory analyst is told not to release a company research report yet. Legal says its current hold is precautionary while issuer factual comments are reviewed. Compliance adds that the firm recently served in the issuer’s follow-on offering, but the release log does not show whether any offering-related publication restriction is still active. Before deciding whether the report may be published, what must the supervisory analyst confirm first?
Best answer: B
Explanation: A possible mandatory publication restriction must be resolved before any prudential legal or compliance hold can be evaluated as the remaining obstacle.
The key missing fact is whether a rule-based publication restriction is still in effect. A mandatory quiet period or similar blackout controls whether publication is permissible at all, while a legal or compliance hold for review is generally a prudential internal control.
This question turns on the difference between a mandatory publication restriction and a prudential hold. When the firm recently participated in an offering, the supervisory analyst must first determine whether an offering-related quiet period or other mandatory restriction is still active. That issue goes to basic permissibility: if the restriction applies, the report cannot be published regardless of whether legal has finished a precautionary review.
A prudential hold imposed by legal or compliance can still delay release, but it does not replace the need to confirm whether publication is prohibited by rule or required restriction status. In the stem, legal has already described its hold as precautionary, so the missing threshold fact is the firm’s underwriting role and timing relative to any applicable quiet-period limit. Only after that is resolved should the analyst treat legal review, disclosures, and release mechanics as the remaining approval items.
Topic: Research Communications Review
A supervisory analyst is asked to approve a one-page notice changing a covered issuer from Hold to Buy and raising its price target during a follow-on offering in which the firm is a distribution participant. Assume the issuer and the firm’s research program otherwise satisfy the applicable regular-course research safe-harbor conditions. Under Regulation M, what best supports disseminating the notice?
Best answer: C
Explanation: Regulation M permits dissemination during a distribution when the communication fits the applicable research-report safe harbor, not merely because it is brief.
The key issue is whether the rating-change notice fits an applicable research-report safe harbor while the firm is a distribution participant. If it qualifies as regular-course research under Rule 138 or 139, dissemination may proceed; its short format alone does not create an exception.
Under Regulation M, a firm participating in a distribution generally cannot publish or distribute communications that could stimulate market interest in the offered security unless an applicable exception applies. A rating-change or price-target-change notice is not automatically permissible just because it is short or limited in content. The best basis for dissemination is that the notice qualifies as a research report under the firm’s regular-course research safe harbor, typically tied to Securities Act Rule 138 or Rule 139.
Reg AC deals with analyst certification, not publication timing relief. Calling the notice a public appearance summary does not change its character if it is being distributed as written research. Limiting the audience to institutions also does not itself remove Regulation M restrictions. The controlling question is whether the communication fits the applicable research safe harbor during the distribution.
Topic: Research Communications Review
A member firm’s compliance officer asks which FINRA rule should be consulted to determine whether an employee must be registered before approving a research report, and which rule should then be used to identify the proper registration category for that approval role. Which response is most accurate?
Best answer: A
Explanation: Rule 1210 is the function-based registration requirement, while Rule 1220 supplies the specific registration categories used to match that function.
The key distinction is framework versus category. Rule 1210 addresses the need for appropriate registration based on the work being performed, while Rule 1220 sets out the registration categories used to classify that role, including principal roles relevant to research approval.
For a supervisory analyst or other approving principal, the firm first asks a threshold question: must this person be registered for the function being performed? That is the Rule 1210 inquiry. Once registration is required, the next question is which registration category fits the person’s duties. That is the Rule 1220 inquiry.
In practice, if someone will approve research-related communications, the firm cannot stop at job title alone. It must confirm that the person is required to be registered for that function under Rule 1210 and then confirm that the person holds the proper category under Rule 1220. Qualification exams and continuing education matter, but they do not change this basic division of labor between the two rules.
The common trap is reversing the rules or confusing registration architecture with content or disclosure rules.
Topic: Research Communications Review
A supervisory analyst reviews a draft research report with an Outperform rating. The thesis depends on margin expansion from a new product launch and continued sales to two customers that account for 40% of revenue. The draft risk section states only: “Equity investments involve market volatility and macroeconomic uncertainty.” Which addition would best make the report’s discussion balanced before approval?
Best answer: A
Explanation: Balanced discussion requires material risks tied to the stated thesis, not just generic market warnings.
A balanced research report should discuss material risks that could undermine its stated investment thesis. Here, the bullish case depends on a product rollout and a concentrated customer base, so the risk discussion should address those specific vulnerabilities rather than rely on boilerplate language.
The key fair-balance issue is whether the report presents meaningful downside factors connected to its recommendation. When a thesis rests on particular drivers, such as successful product execution and continued purchases from a small number of large customers, the risk section should explain how failure of those drivers could weaken the recommendation or price target.
A supervisory analyst should look for risk disclosure that is:
Generic warnings about market volatility are too broad to cure an unbalanced presentation. Likewise, rating-system detail, analyst certification, and approval records may be required for other reasons, but they do not substitute for substantive discussion of material risks.
Topic: Research Communications Review
A supervisory analyst reviews a draft company research update on a covered issuer. The draft states: “Channel checks suggest demand is soft” and “In our view, margins will remain under pressure”. It also states: “Desk chatter indicates the company will be acquired within two weeks,” with no source verification. Required firm disclosures and the analyst’s Regulation AC certification are included, and no restricted-list or quiet-period issue applies. What is the primary approval concern?
Best answer: C
Explanation: Research may include facts and analyst opinion, but unverified rumor should not be presented in a research communication as a basis for the recommendation.
The key issue is the acquisition statement based on “desk chatter” without verification. A research communication may distinguish facts from analyst opinion, but it should not include unverified rumor as substantive support for the analysis or recommendation.
The supervisory analyst’s primary task here is to separate permissible content from impermissible content in the draft. “Channel checks suggest demand is soft” can be evaluated as a factual or sourced analytical input, and “In our view, margins will remain under pressure” is clearly framed as analyst opinion. The acquisition statement is different because it is based on unverified market chatter and is presented as if it were usable information.
Before approval, the supervisory analyst should require that the rumor be removed or independently verified and properly characterized. The stated facts already eliminate more peripheral issues: required disclosures are present, Regulation AC is complete, and no restricted-list or quiet-period restriction applies.
The deciding concept is that rumor is neither acceptable fact nor protected merely because it appears alongside opinion.
Topic: Research Communications Review
A supervisory analyst reviews a draft research report on an issuer. The first page features the heading “Buy now for 80% upside” in oversized bold type above a full-page bullish graphic. Material downside risks appear only in smaller-font text on the final page under “Additional Information.” Required ownership, investment banking, and analyst disclosures are otherwise included, and no restricted-list or quiet-period issue exists. What is the primary compliance risk?
Best answer: A
Explanation: Emphasizing upside through headings, placement, and formatting while burying material risks in low-prominence text makes the report unfairly promotional.
The main issue is the report’s overall presentation, not the absence of boilerplate. Prominent upside messaging and graphics, combined with low-visibility risk text placed at the end, make the communication unfairly promotional and not fair and balanced.
A supervisory analyst must assess not only whether risks are mentioned, but also whether the communication presents them with adequate prominence and balance. Here, the report leads with an oversized bullish claim and a strong positive visual, while material downside risks are pushed to the final page in smaller font. That ordering and formatting can mislead readers by making the positive message dominant and the risk discussion easy to overlook.
Fair-balance review is about the overall impression created by the communication. A risk section does not cure the problem if presentation choices make the piece read like a promotion rather than balanced research. When benefits are highlighted and risks are buried, the primary red flag is the communication’s unfairly promotional character, not an approval-path or certification issue.
The key takeaway is that prominence, placement, and readability matter as much as inclusion.
Topic: Research Communications Review
A supervisory analyst is reviewing a single-issuer research report scheduled for same-day website posting and email distribution. The analyst certification is complete, the issuer reviewed only factual statements, and the security is not on a restricted list. In the valuation section, the report presents base, bear, and bull scenarios, but the bull case says the stock “could easily double from here” without a stated time horizon, operating assumptions, or supporting analysis. What is the best supervisory action before approving dissemination?
Best answer: D
Explanation: A supervisory analyst should not approve aspirational upside language unless it is grounded in disclosed assumptions, time horizon, and supporting analysis.
Scenario analysis is permissible only when each scenario has a reasonable basis and is tied to stated assumptions. Here, the bull case is merely aspirational upside language, so the supervisory analyst should stop dissemination until the statement is supported or removed.
The key issue is whether the optimistic statement is supportable analysis or unsupported promotional language. A research report may include bull, base, and bear scenarios, but each scenario should be anchored to disclosed assumptions, a time horizon, and analysis that gives the opinion a reasonable basis. Saying the stock “could easily double from here” without those elements is not just aggressive; it is inadequately supported and risks being misleading or unbalanced.
The supervisory analyst’s best decision is to withhold approval and require revision. Acceptable fixes would be to remove the statement or rewrite the bull case so it is tied to specific assumptions and evidence in the report. A generic risk disclosure does not cure a missing analytical basis, and issuer input should not be used to validate opinion language. The main takeaway is that optimistic scenario language is allowed only when the report shows why that scenario is reasonably grounded.
Topic: Research Liaison Duties
A supervisory analyst is reviewing the approval file for a research analyst’s upcoming television appearance on issuers in the analyst’s covered sector. The file includes:
- Public-appearance disclosure checklist: complete
- Restricted-list check for discussed issuers: complete
- 90-day analyst trading blotter: attached
- Household account note: spouse's brokerage account listed
- Analyst comment: "I sometimes recommend trades to my spouse, but the account is only in my spouse's name."
Before the appearance is approved, what is the most important missing supervisory step?
Best answer: C
Explanation: When related-account status is unclear, the key supervisory gap is the missing determination of beneficial ownership or control, not a general file enhancement.
The decisive issue is that the spouse’s account may still be a related account even though it is not titled in the analyst’s name. When the analyst may influence trading, the firm needs a documented beneficial-ownership or control review before approval, and the safest interim approach is to treat the account as restricted until that review is finished.
This item tests supervision of related-account conflicts evidence. Title alone does not settle whether an account is a related account. Here, the analyst admits sometimes recommending trades to a spouse, so the firm has an unresolved question about beneficial ownership or trading control.
The supervisory file is missing the core conflict review:
That review is more important than additional recordkeeping around the appearance itself. Retaining talking points, refreshing the checklist, or monitoring the broadcast may be helpful controls, but they do not answer the threshold conflict question of whether the spouse’s account should be treated as a related account.
Topic: Research Communications Review
A firm plans to distribute a one-page notice of a covered issuer’s rating and price-target change. The supervisory analyst learns that sales personnel would receive the notice 20 minutes before clients and the firm’s public release channel because management views it as “not a full research report.” Which statement is most accurate about the supervisory control that best addresses this issue?
Best answer: A
Explanation: The key control is preventing selective pre-release and requiring approved dissemination procedures for research-related communications, including rating-change notices.
A brief notice of a rating or price-target change still raises research dissemination concerns. The best supervisory control is a release process that prevents sales from getting advance access and ensures broad distribution through approved channels at substantially the same time.
Under the research rules framework, the core problem here is selective dissemination, not whether the communication is shorter than a full report. A rating or price-target change notice is still a research-related communication, so the supervisory analyst should verify that firm dissemination controls prevent internal groups such as sales from receiving it ahead of clients or the market. The proper control is an approved release process that uses authorized channels and broad, substantially simultaneous distribution to intended recipients. Issuer preview creates independence concerns, and a later analyst certification does not cure an improper release sequence. The key takeaway is that dissemination architecture matters as much as content review when approving research communications.
Topic: Research Communications Review
A supervisory analyst reviews a draft research update on ABC Corp. It states, “Market talk suggests ABC is in sale discussions and the CEO may resign soon.” The analyst’s support is social-media posts and comments from sales representatives; there is no issuer confirmation, filing, or other independent verification. Which supervisory response is INCORRECT?
Best answer: B
Explanation: Unsupported rumor is not made acceptable by calling it market talk; the supervisory analyst should not approve dissemination on that basis.
Unsupported issuer rumor or market chatter is not a sufficient basis for an approved analyst communication. Labeling it as “unconfirmed market talk” does not cure the problem, so the supervisory analyst should require removal or substantiation before dissemination.
A supervisory analyst must distinguish supported fact and reasoned opinion from rumor. Here, the draft statement rests only on social-media posts and sales comments, with no issuer confirmation or other independent verification. That makes it unsupported market chatter, not research content with a reasonable basis for publication.
At the supervisory level, the proper response is to stop approval until the language is removed or adequately substantiated. Asking for documented support, deleting the statement, or withholding approval pending revision are all consistent with supervising research for fairness and reliability. What is not acceptable is leaving the statement in the communication simply because it is introduced as rumor or chatter.
The key takeaway is that attribution does not convert unsupported rumor into permissible research content.
Topic: Research Communications Review
A supervisory analyst is reviewing two draft company research reports for release today. Report 1 rates Alpha Motors “Buy.” The firm served as co-manager of Alpha’s follow-on offering 5 months ago, and no quiet period applies. Report 2 rates Beta Retail “Neutral.” The firm makes a market in Beta but had no recent investment banking role. Both drafts are otherwise complete. Which disclosure treatment best matches these facts before approval?
Best answer: C
Explanation: A recent co-manager role and market-making status are separate firm-conflict disclosures that should be included before approval.
The supervisory issue is firm-conflict disclosure, not an automatic publication ban. A recent co-manager role in an offering and market-making in the subject security each trigger distinct disclosures that should be present before the supervisory analyst approves the reports.
When a firm has a distribution role or another significant firm interest in the subject security, the supervisory analyst should verify that the research report includes the applicable firm-level disclosures before approval. Here, the firm’s co-manager role in Alpha’s follow-on offering is a recent investment-banking/distribution relationship that must be disclosed. The firm’s market-making activity in Beta is a separate disclosure category and also must be disclosed.
Because the stem states that no quiet period applies and the drafts are otherwise complete, the issue is not whether publication is prohibited. The issue is whether each report accurately discloses the firm’s relevant relationship to the issuer. The common trap is assuming the completed offering role no longer matters or treating any conflict as an automatic bar to publication.
Topic: Research Communications Review
A research analyst submits a company update raising a stock’s rating from Hold to Buy and increasing the price target from $28 to $42. The draft includes the new recommendation and target, but the review file contains no updated model, valuation summary, or written basis beyond “improving momentum.” There are no quiet-period or restricted-list issues. What action should the supervisory analyst take before approving dissemination?
Best answer: D
Explanation: A supervisory analyst should not approve a price target or recommendation that lacks a documented reasonable basis.
The supervisory analyst should stop approval when a new recommendation or price target lacks documented analytical support. A disclosure label or limited distribution does not cure the missing reasonable basis; the support must be added or the unsupported content must be removed before dissemination.
Research supervision requires a reasonable basis for recommendations and price targets before a report is approved for dissemination. Here, the analyst changed both the rating and the target, but the file has no updated model, valuation work, or written analysis showing how the new figures were derived. That makes the communication vulnerable to being unfair, unbalanced, or insufficiently supported.
The proper supervisory response is to withhold approval and require documentation that supports the change, such as updated analysis, valuation assumptions, and related risk discussion, or to remove the unsupported target and recommendation from the draft. Adding a disclaimer does not replace substantive support, and restricting the audience does not make unsupported research acceptable. Asking the issuer to justify the target also raises research-independence concerns.
Topic: Research Communications Review
A covered issuer is on the firm’s watch list because investment banking expects a transaction milestone within days. A supervisory analyst is asked whether a prepared research update may be disseminated. Which statement is most accurate?
Best answer: D
Explanation: A watch-list name is not automatically barred from publication, but it requires tighter dissemination controls and escalation as transaction risk increases.
A watch list generally triggers heightened monitoring and tighter dissemination controls, not an automatic publication ban. As an investment-banking event nears, the supervisory response is to restrict access on a need-to-know basis, escalate review, and be prepared to move the issuer to a restricted list if the risk warrants it.
The key concept is that a watch list is a surveillance and control tool, while a restricted list is the stronger publication constraint. When a watch-list issuer is approaching an investment-banking milestone, the supervisory analyst should not treat dissemination as either fully routine or automatically forbidden. Instead, the firm should tighten need-to-know access, increase prepublication scrutiny, coordinate with compliance and legal, and assess whether the circumstances now justify restricted-list treatment.
Standard disclosures do not cure a dissemination-control problem, and narrowing release to a favored audience does not solve it. The supervisory focus is on preventing improper use of sensitive information and avoiding selective or poorly controlled distribution as the transaction risk becomes more acute.
Topic: Research Liaison Duties
A supervisory analyst learns that an equity analyst plans to call 15 institutional clients 30 minutes before a scheduled system release of an already approved downgrade report. On the calls, the analyst would give the new rating and a brief summary of the reasons. Reg AC certification is complete, required disclosures are included, and no trading or banking restriction applies. What is the best next step?
Best answer: A
Explanation: Pre-release oral summaries to selected institutions are a selective dissemination concern, so the report must be distributed through controlled channels before any client gets the substance early.
The issue is not report approval or analyst certification; it is unequal access. Giving selected institutional clients the new rating and reasons before formal release is a selective dissemination problem, so the supervisory analyst should block the preview and require controlled dissemination first.
This scenario turns on dissemination control. Even though the report is already approved and the Reg AC and disclosure steps are complete, selected institutional clients cannot receive the substance of the research action before the firm’s formal release. An oral preview of the downgrade and its basis would give favored recipients an early informational advantage.
The proper sequence is to stop the pre-release calls and ensure the report is distributed through the firm’s approved dissemination process, with normal release records preserved. If a communication has not yet been formally disseminated, the supervisory concern is preventing selective access, not adding more wording or involving the issuer. A legend does not cure unequal timing, and issuer review raises a different independence concern.
Topic: Research Liaison Duties
A research analyst received preclearance at 9:00 a.m. to buy 200 shares of Delta Motors in a personal account. At 10:15 a.m., the firm’s rating-change notice on Delta was accelerated for noon release, and compliance immediately placed Delta on the restricted list. Firm policy states that any precleared personal trade must be canceled if, before execution, the issuer enters a publication blackout or is placed on the restricted list. Before deciding whether the prior approval still stands, what must the supervisory analyst confirm first?
Best answer: D
Explanation: If the order was still unexecuted when Delta entered the blackout and restricted-list period, the earlier preclearance must be canceled.
The key issue is execution timing. A preclearance may be valid when granted, but if publication timing or list status changes before the trade executes, the approval no longer supports the trade and the order must be canceled.
This tests personal-account trading controls around changed circumstances. When a trade has been precleared, that approval is not a permanent safe harbor. If the issuer is later placed on a restricted list or enters a publication-related blackout before the order is executed, the controlling question is whether execution already occurred while the approval was still valid.
If execution had already occurred, the later restriction does not retroactively cancel the completed trade. If the order was still open or unfilled when the restriction began, the trade can no longer rely on the earlier approval and should be canceled. Items like annual holdings reporting, Reg AC paperwork, or share-count matching may matter for other reviews, but they do not answer the immediate cancel-or-allow decision here.
Topic: Research Communications Review
A supervisory analyst is reviewing the approval package for a finalized company research report intended for all firm customers. The file includes the draft report, required conflict disclosures, the analyst’s Reg AC certification, restricted-list and watch-list clearance, and supervisory analyst approval. The dissemination instruction says: “At 8:00 a.m., sales emails the PDF to 25 institutional clients; at 8:20 a.m., the same report is posted to the firm portal for all other customers.” Under FINRA Rule 2241, which item is still deficient?
Best answer: C
Explanation: Rule 2241 requires policies and controls reasonably designed to prevent selective distribution of research reports to some customers before all intended customers can access them.
The package already contains the core approval and disclosure documents, but the release plan still permits selective dissemination. Under FINRA Rule 2241, a firm must have controls reasonably designed to avoid giving some intended recipients the report before others.
The decisive issue is how the report will be disseminated. Even with disclosures, Reg AC, restricted-list clearance, and supervisory approval in place, the stated release plan lets a subset of customers receive the report 20 minutes before the rest of the intended audience. FINRA Rule 2241 requires firms to maintain policies and procedures reasonably designed to ensure research reports are not selectively distributed to particular customers before they are made available to all customers for whom the report is intended.
A proper control would route the final report through an approved channel that provides substantially simultaneous access to the full intended audience, rather than allowing sales to send it early to favored accounts. The problem is not the report content; it is the deficient dissemination control.
Topic: Research Communications Review
A supervisory analyst is reviewing proposed opening lines for a company research report. Forward-looking views are permitted, but the language must not present speculation to customers as established fact. Which proposed sentence is most appropriate for approval?
Best answer: A
Explanation: This choice states a forward-looking opinion with a stated basis and acknowledges uncertainty rather than claiming a future outcome as fact.
Permissible research may include forward-looking opinion when it is framed as an expectation, tied to a reasonable basis, and not stated as guaranteed fact. The acceptable sentence does that by using opinion language, citing announced store openings, and noting execution risk.
The core issue is whether the communication presents a forecast as a reasoned opinion or as a certainty. In research, a forward-looking view can be approved when it is clearly identified as an expectation or belief, is grounded in some stated basis, and avoids exaggerated or promissory language. Here, the acceptable sentence says “we expect,” ties the view to announced store openings, and notes that delays could change the outcome.
By contrast, language saying revenue “will” grow treats a future event as established fact. Claiming channel checks “prove” contract wins and “ensure” growth improperly turns uncertain information into certainty and may also suggest rumor-like sourcing. Telling investors they can “count on” appreciation is promissory and unbalanced. A management plan or optimistic view may support analysis, but it does not justify presenting future performance as guaranteed.
Topic: Research Communications Review
A firm’s written supervisory procedures require that any single-issuer research communication be approved and released through the home-office research control group by a Series 16-qualified supervisory analyst. While that reviewer is away, a regional branch manager who is not designated in the procedures approves and emails a rating-change notice from the branch office. The notice already contains the required disclosures and the analyst’s Reg AC certification. What is the primary compliance risk?
Best answer: A
Explanation: NYSE Rule 342(b)(1) focuses on whether the office had the proper supervisory structure and designated control over approval and release before dissemination occurred.
The key problem is not disclosure content but supervisory architecture. The firm required release through a designated home-office control function and a qualified supervisory analyst, yet the branch office released the communication through an undesignated person, creating the primary office supervision and control failure.
This item tests office approval, supervision, and control obligations. When a firm’s procedures require research communications to be reviewed and released through a designated office and qualified supervisory analyst, a branch office cannot simply substitute a local manager who is not part of that control structure. The main red flag is the breakdown in the firm’s supervisory chain and office controls before dissemination.
Under this framework, the supervising question is whether the communication was approved and released through the proper office, by the proper person, under the firm’s established controls. Here, the draft already had required disclosures and Reg AC, so content was not the decisive issue. The decisive issue was unauthorized release outside the firm’s designated approval structure. A later legal review or a fuller report would not cure that initial control failure.
Topic: Research Liaison Duties
A supervisory analyst is coordinating release of an issuer downgrade. Firm policy allows sales and trading to receive only administrative details needed for systems, staffing, and broad dissemination; they may not influence research content or publication timing. Which action is NOT appropriate?
Best answer: D
Explanation: Delaying research so the desk can manage inventory improperly lets trading interests influence publication timing.
The prohibited step is delaying the downgrade so the trading desk can reduce its position. Administrative coordination may cover logistics such as systems setup, staffing, and release timing, but sales and trading cannot pressure research timing or substance for trading advantage.
The core issue is research independence. A supervisory analyst may coordinate with sales and trading on administrative mechanics that support an orderly, broad release of research, such as confirming identifiers, planning staffing, or communicating the public release time once approved. Those steps are permissible only if they do not preview the report’s substance and do not alter when or how the research is published.
The line is crossed when trading interests affect publication timing or content. Holding a downgrade until the desk reduces inventory subordinates research to the firm’s trading position and is inconsistent with the independence expected of research communications. If sales or trading seeks a delay or content change for business reasons, the supervisory analyst should reject the request and escalate under firm legal/compliance procedures.
Topic: Research Liaison Duties
A supervisory analyst is closing the review file for a research analyst’s unscripted television interview about a covered issuer. Pre-event approval of the appearance is already documented, and no written script was used. Before the file can be treated as complete, what must the supervisory analyst confirm is retained to evidence the disclosures made during the public appearance?
Best answer: C
Explanation: For an unscripted public appearance, the key retained evidence is a record showing what disclosures were actually made during the event.
For a public appearance, the firm needs retained evidence of the disclosures actually delivered, not just preparation materials or general compliance documents. In an unscripted interview, that means confirming a recording, transcript, or comparable contemporaneous record is in the file.
The core issue is post-event documentation for a research analyst public appearance. Because the interview was unscripted, pre-event approval alone does not prove which disclosures were actually communicated to the audience. The supervisory analyst should confirm that the firm retained a record of the appearance itself, or another contemporaneous record, sufficient to evidence the disclosures made and support supervisory review.
This record can take the form of:
Preparation materials, research support, and annual policy acknowledgments may be useful elsewhere, but they do not establish what was said on air. The deciding point is evidence of the actual disclosures made during the event.
Topic: Research Liaison Duties
A supervisory analyst is reviewing release controls for two already-approved communications with all required disclosures completed.
Which statement best matches the supervisory analyst’s concern?
Best answer: D
Explanation: It gives a limited recipient group the rating change before synchronized broader dissemination, creating an avoidable selective-release risk.
The problem is not the type of channel but the lack of synchronized release. Sending a single-issuer rating change to a narrower group before broader distribution is a dissemination-control weakness, while simultaneous email and portal release of broad market commentary is generally consistent with controlled dissemination.
The core concept is release sequencing across channels and recipient groups. For research communications, the supervisory analyst should confirm that dissemination controls do not allow one favored group to receive a market-moving research view before the firm’s intended broader audience. In the stem, the single-issuer rating downgrade is sent to the institutional sales desk five minutes early, so timing and recipient groups are not aligned.
A sound control framework generally requires that:
By contrast, the broad-based market strategy note is released through both approved channels at the same time, so the stated facts do not show the same sequencing weakness. The key takeaway is that prior approval and complete disclosures do not cure an unsynchronized release plan.
Topic: Research Communications Review
A supervisory analyst reviews a draft company research report that states: We rate ABC Corp. Buy with a price target of \$48, based on margin recovery and a better demand environment. The draft does not state the time horizon for the target or the operating conditions assumed. Regulation AC certification is signed, required conflict disclosures are complete, and dissemination has not begun. What is the best next step?
Best answer: B
Explanation: Supervisory approval should wait until the report clearly states the price target’s time horizon and key operating conditions in the report itself.
Before a supervisory analyst approves a report, the price target must be presented clearly enough to be understood by investors. If the report omits the target’s time horizon and the operating conditions on which it depends, the proper next step is to send it back for revision before approval and dissemination.
This question tests supervisory approval of a research report’s price target discussion. A price target is not adequately presented if the report gives only a number and vague support, but fails to state the period over which the target is expected to be achieved and the assumptions or operating conditions that make the target reasonable. Because the certification and conflict disclosures are already complete, the missing item is not legal routing or disclosure processing; it is a substantive report deficiency that must be fixed before approval.
In sequence, the supervisory analyst should:
A generic risk disclosure does not cure an unclear price target, and post-release correction is too late for an avoidable approval issue.
Topic: Research Communications Review
A supervisory analyst is reviewing a draft company research report that changes a rating from Neutral to Buy and raises the price target from $28 to $40. The draft includes required disclosures and a completed Reg AC certification, and the issuer is not on a restricted list. However, the file contains no revised model, assumptions, or support memo for the new target or recommendation. What is the best next step?
Best answer: B
Explanation: A supervisory analyst should not approve or allow dissemination of a price target or recommendation that lacks documented reasonable-basis support.
The supervisory analyst’s immediate duty is to stop the approval process until the analyst provides adequate analytical support for the changed recommendation and price target. Required disclosures and Reg AC certification do not cure a missing reasonable basis.
When a research report includes a new recommendation or price target, the supervisory analyst must confirm that the view is supported by documented analysis before approving or disseminating the communication. Here, the file is missing the substantive support for the change, such as a revised model, assumptions, or a basis memo. The proper sequence is to withhold approval, return the draft to the analyst for support, and then re-review the report and supporting record before dissemination. Legal or compliance review may be appropriate for other issues, but it does not replace the supervisory determination that the recommendation and target have an adequate analytical basis. Reg AC certification also does not substitute for support. The key takeaway is that disclosure and certification cannot fix an unsupported research conclusion.
Topic: Research Communications Review
A research analyst drafts a single-issuer report reiterating a Buy rating after an earnings beat. The draft highlights revenue growth, margin expansion, and management guidance, but it omits customer-concentration risk and pending litigation that are already known within the firm. Sales asks whether the report can go to clients once the analyst signs the certification. The supervisory analyst concludes the draft is one-sided. What is the best next step?
Best answer: B
Explanation: A research report should be revised to present material risks fairly before supervisory approval and any client distribution.
The supervisory analyst should stop the process until the report is revised to present a fair and balanced discussion of material risks. Analyst certification, later corrections, or the fact that risks are public elsewhere do not cure a one-sided research report before distribution.
The core issue is fair balance in a research report. When a draft emphasizes favorable facts but omits known material risks, the supervisory analyst should require the analyst to revise the report before it is approved or disseminated. A balanced discussion must stand on its own in the communication being reviewed; selective presentation of positive facts is not acceptable simply because the omitted risks exist in public filings or internal records.
In sequence, the proper workflow is:
The closest distractors fail because they either release first, fix later, or send the draft to another reviewer before correcting the basic content problem.
Topic: Research Communications Review
A supervisory analyst is reviewing a draft single-issuer research report and the attached disclosure note. Based solely on the exhibit, which conclusion is fully supported before approval?
Exhibit:
Draft disclosure note
- Analyst certification: included
- Analyst beneficial ownership of issuer shares: none
- Analyst's sibling works for the issuer as a software engineer and does not live with the analyst
- Member firm makes a market in the issuer's common stock
- Member firm received no investment banking compensation from the issuer in the past 12 months
Best answer: B
Explanation: Market making is a firm-level conflict that requires express disclosure, and nothing in the exhibit removes that requirement.
The exhibit shows one clear disclosable firm conflict: the member firm makes a market in the subject security. A supervisory analyst should treat that as requiring express disclosure before approving the report.
This item turns on separating a required conflict disclosure from facts that do not, by themselves, materially change the research communication. The exhibit identifies market making by the member firm, which is a classic firm-level conflict that must be disclosed in a research report. By contrast, a sibling who does not live with the analyst is not the same as a household-member conflict, and the exhibit gives no added facts suggesting that relationship is material enough to require separate disclosure. Analyst certification also serves a different purpose: it confirms the analyst’s views and compensation representation, but it does not replace required conflict disclosures. Likewise, no investment banking compensation in the past 12 months only eliminates that specific disclosure category. The key takeaway is that one listed conflict can still require disclosure even when other common conflicts are absent.
Topic: Research Communications Review
A supervisory analyst approved a company rating-change notice for external release at 9:00 a.m. The file contains the analyst certification, standard research disclosures, and the approval log. At 10:15 a.m., Compliance placed the issuer on the firm’s restricted list because the firm accepted a role in a follow-on offering. The notice is still queued for external distribution at 10:30 a.m., and the file shows no further review entry.
Which missing control is the most significant supervisory deficiency?
Best answer: B
Explanation: Once restricted-list status changes before release, dissemination must be stopped pending compliance review rather than relying on the earlier approval.
The key issue is that approval occurred before the issuer was placed on the restricted list, but external release had not yet happened. The missing control is a final dissemination gate that rechecks list status and prevents release when a new restriction arises.
This question turns on dissemination control, not on the quality of the original approval package. A report or rating-change notice that was properly approved can still become impermissible to publish if the issuer’s status changes before external release. The supervisory analyst and the firm need a control that links list-status changes to the release process so distribution is halted and the item is escalated for compliance review.
The closest distractors describe useful records or content enhancements, but they do not address the decisive failure: the absence of a pre-release stop control after a status change.
Topic: Research Communications Review
A firm plans to send a two-page “Weekly Retail Themes” note to retail and institutional clients for the first time today. The main body is broad economic and sector commentary, but the final attachment has not yet been uploaded; the routing note says it “mentions several apparel issuers for reference.” The supervisory analyst must decide whether prior supervisory analyst approval is required before initial distribution. What should be confirmed first?
Best answer: C
Explanation: That fact determines whether the note is merely market commentary or a research communication requiring supervisory analyst approval before first distribution.
The first issue is classification of the communication. If the missing attachment adds issuer-specific analysis, ratings, or price targets, the piece may require supervisory analyst approval before initial distribution; the other facts matter only after that threshold is resolved.
A supervisory analyst should first determine whether the communication is actually a research communication that requires approval before initial use or distribution. Broad market, economic, or sector commentary by itself may not trigger that approval path, but adding issuer-specific analysis, recommendations, ratings, or price targets can change the classification. Here, the unresolved item is the missing attachment, and the routing note is too vague because “mentions issuers for reference” could mean either simple factual mention or substantive investment content. The key missing fact is whether the attachment contains issuer-specific recommendations or similar analytical content. Only after that classification is confirmed do items like Reg AC records or restricted-list status become the next review steps.
Topic: Research Liaison Duties
A supervisory analyst approved a single-issuer research report on ABC Corp., and the firm distributed it this morning by email and through the client portal. Two hours later, compliance determines that a required firm market-making disclosure was omitted. The report has already reached clients, and a corrected version cannot be approved until later today. What is the best supervisory action now?
Best answer: A
Explanation: Because the deficient report was already disseminated and no approved correction is yet available, prior recipients need an affirmative withdrawal communication, not just a prospective hold.
Once a materially deficient report has already been disseminated, the supervisory problem is no longer limited to stopping future distribution. If an approved corrected version is not yet ready, the firm should affirmatively withdraw the report from prior recipients and stop further access until replacement can occur.
The key concept is dissemination control after a withdrawn research report. A hold notice is useful to stop additional distribution, but it does not fix the fact that prior recipients already received a report with a material omission. Here, the report was emailed and posted to the client portal, so the supervisory analyst must address both channels.
The best immediate response is to:
A later replacement report may follow, but until that corrected version is approved, prior recipients should be told the earlier report should not be relied on.
Topic: Research Liaison Duties
A supervisory analyst is reviewing a draft research report on an issuer covered by the firm’s research department. An investment banker asks to delay publication for two days until the banker finishes a financing pitch to the issuer and asks that a risk paragraph be rewritten in a less negative tone to protect the relationship. The banker also notes that the draft disclosure section omits a recently signed advisory engagement. Which action best aligns with research-supervision standards?
Best answer: A
Explanation: Banking input may be used for factual conflict or disclosure accuracy, but not to influence research timing, tone, or independence.
The proper response is to preserve research independence while still capturing factual information needed for accurate disclosures. Banker input cannot be used to shape publication timing or soften analysis for relationship reasons, but factual conflict information can be routed into the disclosure review process.
Under durable research-independence standards, investment banking must not control a research report’s content, tone, or publication timing for business-development purposes. In this scenario, the requests to hold the report until a pitch is completed and to make a risk discussion less negative are improper because they seek to influence research for banking reasons. By contrast, information about a recently signed advisory engagement is factual conflict information that should be reviewed and, if required, added to the disclosure section through the firm’s supervisory process.
The supervisory analyst should separate permissible factual input from impermissible influence:
The key distinction is not whether the banker requests a rating change; it is whether the banker is trying to influence independent research judgment.
Topic: Research Communications Review
A firm is reviewing its research approval controls. Which situation is a deficiency in supervisory analyst qualification, rather than a deficiency in local office supervision, continuing education, or written delegation records?
Best answer: C
Explanation: Approving a research report without the required supervisory analyst registration is a qualification deficiency.
A supervisory analyst qualification deficiency exists when the person approving research lacks the required supervisory analyst registration. The other situations involve supervision, continuing education, or documentation problems, but not the absence of the core qualification itself.
The key distinction is between who is qualified to approve research and other control failures surrounding that approval. A qualification deficiency occurs when the approver does not hold the required supervisory analyst registration for the function being performed. In the stem, the General Securities Principal approved a research report without being registered as a supervisory analyst, so the defect is in the approver’s qualification itself.
By contrast, weak local office oversight is a supervision problem, incomplete continuing education is a CE status problem, and missing written delegation is a recordkeeping or authorization problem. Those issues may still be serious, but they do not change the basic category of the deficiency. The exam often tests whether you can separate a missing required registration from other operational or procedural control failures.
Topic: Research Liaison Duties
A supervisory analyst learns that a draft research report was sent to the issuer for factual verification only. Which issuer comment most clearly exceeds that boundary and should be escalated to legal or compliance before the report is approved?
Best answer: A
Explanation: This request goes beyond factual verification by using nonpublic information to influence analytical language, requiring escalation before approval.
Issuer review of draft research is generally limited to factual verification. A request to revise risk analysis using undisclosed sales data crosses that line because it may involve MNPI and attempts to shape the analyst’s opinion, so it should be escalated before approval.
The core boundary is that issuers may help verify facts, but they should not use draft review to influence the analyst’s judgment or inject unpublished operating information into the report. A request to soften a risk discussion based on undisclosed monthly sales data is not a routine fact check; it raises legal/compliance concerns because the comment is tied to nonpublic information and to the substance of the analysis.
Routine factual corrections are different. Fixing a typo, updating shares outstanding from a filed report, or matching a debt maturity date to a filed document are ordinary verification items that can be addressed through normal review controls. When issuer feedback moves from fact checking to changing conclusions, tone, recommendation, or analysis—especially with nonpublic support—the supervisory analyst should escalate before approving dissemination.
The key takeaway is that factual verification is permissible; issuer influence over analytical content is not.
Topic: Research Communications Review
A supervisory analyst approved a company research report with a Buy rating and a $50 price target. Before dissemination, the analyst revises the draft to Hold, lowers the price target to $38, rewrites the investment thesis, and updates a disclosure. Firm policy states that any material change to the rating, price target, thesis, or disclosures after approval requires reapproval. Which response is INCORRECT?
Best answer: D
Explanation: Material post-approval changes to the rating, price target, thesis, or disclosures require reapproval before the report may be disseminated.
Material revisions made after a supervisory analyst has approved a report require a fresh approval before dissemination. Changing the rating, price target, thesis, and disclosures is not a minor edit, so the original approval cannot simply carry forward.
The core concept is that supervisory analyst approval attaches to the version actually reviewed. When a draft is materially changed after approval, especially in core elements like the rating, price target, investment thesis, or required disclosures, the revised draft must be reapproved before publication or distribution.
In this scenario, the revisions affect multiple central research elements:
That makes reliance on the earlier approval inappropriate. The proper control is to stop dissemination, obtain approval of the revised draft, and keep records showing what version was ultimately approved. The closest distractor is the idea that timing matters because the report has not yet been published, but material changes trigger reapproval regardless of whether dissemination has occurred.
Topic: Research Communications Review
A broker-dealer receives a favorable report on ABC Biotech from an unaffiliated research boutique. Before sending it to retail customers, the sales desk reformats the report into the firm’s template, adds the firm’s logo and a short introduction, and plans to distribute it through the firm’s research email list today; ABC Biotech is not on the firm’s restricted list. No supervisory analyst has reviewed the republished piece. What is the best supervisory analyst action?
Best answer: C
Explanation: Reformatting and firm branding make the third-party report attributable to the firm, triggering pre-dissemination supervisory analyst review.
The firm has done more than merely pass along independent third-party research. By reformatting the piece into its own template, adding its logo, and using its research distribution channel, the firm has made the communication attributable to itself, so supervisory analyst review should occur before customer dissemination.
The key issue is attribution. When a firm republishes third-party research in a firm-branded format and distributes it through its own research channel, the communication is no longer just neutral access to outside content; it has been adopted or republished in a way that makes it the firm’s research communication for supervisory purposes. That means the firm should not disseminate it until the required supervisory analyst review and approval are completed.
Source identification, copyright review, and the fact that the issuer is not on a restricted list may all matter, but none of them cures the missing approval. The decisive fact pattern is the firm’s branding and repackaging of the report before customer distribution. By contrast, a more passive availability arrangement for truly independent third-party research may be analyzed differently, but that is not what these facts describe.
Topic: Research Liaison Duties
For an already-distributed research report, which development most clearly requires urgent corrective redistribution instead of a routine update workflow?
Best answer: A
Explanation: A material mistake or missing required disclosure in a distributed report must be corrected and redistributed promptly, not handled as an ordinary update.
Urgent corrective redistribution is triggered when a report already sent to recipients contains a material error or leaves out a required disclosure. Routine updates cover normal maintenance, refreshed analysis, or expanded commentary that do not correct a material defect in previously distributed research.
The key distinction is whether the firm is fixing a defect in research that has already been disseminated. If a published report contains a material error or omits a required disclosure, the issue is not a normal update cycle item; it requires prompt corrective action and redistribution so prior recipients are not left with misleading or incomplete information.
Routine update workflows apply to ordinary research maintenance, such as refreshing statistics, revising future assumptions, or adding context for a later publication. Those changes may require normal review and approval, but they do not carry the same urgency as correcting a material problem in an existing distributed report. The takeaway is simple: previously disseminated misinformation or missing mandated disclosure triggers corrective redistribution controls.
Topic: Research Liaison Duties
A supervisory analyst is reviewing proposed contacts between investment banking and the research department regarding an issuer covered by the firm. Which contact is most consistent with research-independence rules?
Best answer: B
Explanation: Administrative timing information used to enforce restrictions is permitted because it supports compliance controls rather than influencing the report’s substance.
Research-independence rules permit coordination contacts that are administrative or compliance-related, such as sharing offering timing so the firm can impose publication and dissemination controls. They bar investment banking from influencing the substance, timing, rating, price target, or tone of research.
The key distinction is coordination versus influence. Investment banking may communicate factual scheduling or transaction-status information when the purpose is to let compliance or supervisory personnel apply controls such as restricted-list placement, quiet-period handling, or dissemination limits. That kind of contact supports the firm’s research architecture and does not direct the analyst’s views.
What is barred is any banking input that affects research substance or publication judgment, including:
So the permissible contact is the one limited to timing information for compliance controls, not editorial or analytical input.
Topic: Research Liaison Duties
A supervisory analyst reviews proposed research-related communications under the firm’s policy:
Which statement is INCORRECT under this policy?
Best answer: C
Explanation: An unpublished rating change cannot be previewed to selected salespeople without compliance preapproval, even if the report wording is final.
The inaccurate statement is the one allowing a pre-release downgrade discussion with selected salespeople without compliance review. Unpublished rating or price-target changes raise dissemination and coordination concerns, so compliance must be involved before that communication proceeds.
The core concept is escalation before the communication, not after it. When a planned interaction involves an unpublished rating or price-target change, uncertain watch-list or restricted-list status, or an issuer exchange that moves beyond factual verification, legal or compliance review is required before the discussion continues. Those controls help prevent selective dissemination, improper sales/trading coordination, and issuer influence over research content. By contrast, once a report has been properly approved and broadly disseminated, routine delivery of that same report to a requesting client through normal sales channels is generally ordinary distribution, not a new approval event. The common mistake is treating a “final” draft as safe to preview; final wording does not eliminate the need for compliance control.
Use the Series 161 Practice Test page for the full Securities Prep route, mixed-topic practice, timed mock exams, explanations, and web/mobile app access.
Review weak areas with the Series 161 Cheat Sheet , then continue with the complete Securities Prep route from the FINRA Series 161 Practice Test page.